Yifeng Pharmacy reports modest revenue, strong profit growth in first half

For the first half of 2025, Yifeng Pharmacy Chain recorded a revenue of CNY 11.72 bn, a marginal decrease of 0.35% year-over-year. Despite this, the company saw a significant rise in net profit attributable to shareholders, reaching CNY 880m, up 10.32% from the previous year. Non-recurring net profit also grew by 9.08% to CNY 857m. Retail business revenue experienced a slight decline of 1.91% to CNY 10.199 bn, while franchise and distribution revenue increased by 17.20% to CNY 1.169 bn.

The company's online sales, including O2O and B2C, generated CNY 1.355 bn in the first half of 2025. Yifeng Pharmacy is actively expanding its non-pharmaceutical business, focusing on functional and non-functional foods, as well as beauty and personal care products. The company also announced a mid-year cash dividend of CNY 0.30 per share, totaling CNY 364m, representing 41.33% of its half-year net profit.

Yifeng Pharmacy is integrating AI technology across its operations, particularly in staff training, customer service, and store management, aiming to enhance professional service efficiency and customer satisfaction. The company is also actively collaborating with various commercial insurance providers to support the multi-tiered medical protection system and expects this segment to contribute to future growth.